4//SEC Filing
Chan Heng Fai Ambrose 4
Accession 0001641172-25-002819
CIK 0001834105other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:15 PM ET
Size
22.8 KB
Accession
0001641172-25-002819
Insider Transaction Report
Form 4
CHAN FAI
Director10% Owner
Transactions
- Sale
Common stock
2025-04-02$0.58/sh−300,000$174,300→ 553,904 total(indirect: See footnote) - Sale
Common stock
2025-04-02$0.67/sh−200,000$134,800→ 353,904 total(indirect: See footnote) - Sale
Common stock
2025-04-02$0.67/sh−2,349$1,581→ 351,555 total(indirect: See footnote) - Sale
Common stock
2025-04-02$0.58/sh−382,427$222,955→ 351,631 total(indirect: See footnote) - Sale
Common stock
2025-04-03$0.58/sh−351,631$203,594→ 0 total(indirect: See footnote) - Sale
Common stock
2025-04-03$0.78/sh−273,286$212,890→ 180,000 total(indirect: See footnote) - Sale
Common stock
2025-04-04$0.96/sh−180,000$172,800→ 0 total(indirect: See footnote)
Alset International Ltd
10% Owner
Transactions
- Sale
Common stock
2025-04-02$0.58/sh−300,000$174,300→ 553,904 total(indirect: See footnote) - Sale
Common stock
2025-04-04$0.96/sh−180,000$172,800→ 0 total(indirect: See footnote) - Sale
Common stock
2025-04-02$0.67/sh−200,000$134,800→ 353,904 total(indirect: See footnote) - Sale
Common stock
2025-04-02$0.67/sh−2,349$1,581→ 351,555 total(indirect: See footnote) - Sale
Common stock
2025-04-03$0.78/sh−273,286$212,890→ 180,000 total(indirect: See footnote) - Sale
Common stock
2025-04-02$0.58/sh−382,427$222,955→ 351,631 total(indirect: See footnote) - Sale
Common stock
2025-04-03$0.58/sh−351,631$203,594→ 0 total(indirect: See footnote)
Alset Inc.
10% Owner
Transactions
- Sale
Common stock
2025-04-02$0.58/sh−300,000$174,300→ 553,904 total(indirect: See footnote) - Sale
Common stock
2025-04-02$0.58/sh−382,427$222,955→ 351,631 total(indirect: See footnote) - Sale
Common stock
2025-04-03$0.78/sh−273,286$212,890→ 180,000 total(indirect: See footnote) - Sale
Common stock
2025-04-04$0.96/sh−180,000$172,800→ 0 total(indirect: See footnote) - Sale
Common stock
2025-04-02$0.67/sh−200,000$134,800→ 353,904 total(indirect: See footnote) - Sale
Common stock
2025-04-02$0.67/sh−2,349$1,581→ 351,555 total(indirect: See footnote) - Sale
Common stock
2025-04-03$0.58/sh−351,631$203,594→ 0 total(indirect: See footnote)
Footnotes (8)
- [F1]On April 2, 2025, Alset International Limited sold 300,000 shares of the Issuer's common stock at a weighted average sale price of $0.581. This transaction was executed in multiple trades at prices ranging from $0.551 to $0.607. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]On April 2, 2025, Alset International Limited sold 200,000 shares of the Issuer's common stock at a weighted average sale price of $0.674. This transaction was executed in multiple trades at prices ranging from $0.67 to $0.80. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]On April 2, 2025, Alset International Limited sold 2,349 shares of the Issuer's common stock at a weighted average sale price of $0.673. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F4]On April 2, 2025, Alset Inc. sold 382,427 shares of the Issuer's common stock at a weighted average sale price of $0.583. This transaction was executed in multiple trades at prices ranging from $0.57 to $0.63. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F5]On April 3, 2025, Alset Inc. sold 351,631 shares of the Issuer's common stock at a weighted average sale price of $0.579. This transaction was executed in multiple trades at prices ranging from $0.50 to $0.73. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F6]On April 3, 2025, Global Biomedical Pte. Ltd. sold 273,286 shares of the Issuer's common stock at a weighted average sale price of $0.779. This transaction was executed in multiple trades at prices ranging from $0.75 to $0.84. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F7]On April 4, 2025, Global Biomedical Pte. Ltd. sold 180,000 shares of the Issuer's common stock at a weighted average sale price of $0.96 This transaction was executed in multiple trades at prices ranging from $0.93 to $0.997. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F8]Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc. Mr. Chan now may be deemed to be the beneficial owner of the 351,555 shares of common stock held by Alset International Limited.
Documents
Issuer
IMPACT BIOMEDICAL INC.
CIK 0001834105
Entity typeother
Related Parties
1- filerCIK 0001261725
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 5:15 PM ET
- Size
- 22.8 KB